BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10597225)

  • 1. Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations.
    Corcoran MM; Mould SJ; Orchard JA; Ibbotson RE; Chapman RM; Boright AP; Platt C; Tsui LC; Scherer SW; Oscier DG
    Oncogene; 1999 Nov; 18(46):6271-7. PubMed ID: 10597225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequencing of t(2;7) translocations reveals a consistent breakpoint linking CDK6 to the IGK locus in indolent B-cell neoplasia.
    Parker EP; Siebert R; Oo TH; Schneider D; Hayette S; Wang C
    J Mol Diagn; 2013 Jan; 15(1):101-9. PubMed ID: 23127611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translocation t(2;7)(p12;q21-22) with dysregulation of the CDK6 gene mapping to 7q21-22 in a non-Hodgkin's lymphoma with leukemia.
    Brito-Babapulle V; Gruszka-Westwood AM; Platt G; Andersen CL; Elnenaei MO; Matutes E; Wotherspoon AC; Weston-Smith SG; Catovsky D
    Haematologica; 2002 Apr; 87(4):357-62. PubMed ID: 11940479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of a t(2;7) translocation linking CDK6 to the IGK locus in CD5(-) monoclonal B-cell lymphocytosis.
    Parker E; Macdonald JR; Wang C
    Cancer Genet; 2011 May; 204(5):260-4. PubMed ID: 21665179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion mapping on the long arm of chromosome 7 in splenic lymphoma with villous lymphocytes.
    Gruszka-Westwood AM; Hamoudi R; Osborne L; Matutes E; Catovsky D
    Genes Chromosomes Cancer; 2003 Jan; 36(1):57-69. PubMed ID: 12461750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput sequencing analysis of the chromosome 7q32 deletion reveals IRF5 as a potential tumour suppressor in splenic marginal-zone lymphoma.
    Fresquet V; Robles EF; Parker A; Martinez-Useros J; Mena M; Malumbres R; Agirre X; Catarino S; Arteta D; Osaba L; Mollejo M; Hernandez-Rivas JM; Calasanz MJ; Daibata M; Dyer MJ; Prosper F; Vizcarra E; Piris MÁ; Oscier D; Martinez-Climent JA
    Br J Haematol; 2012 Sep; 158(6):712-26. PubMed ID: 22816737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translocation t(2;7)(p11;q21) associated with the CDK6/IGK rearrangement is a rare but recurrent abnormality in B-cell lymphoproliferative malignancies.
    Douet-Guilbert N; Tous C; Le Flahec G; Bovo C; Le Bris MJ; Basinko A; Morel F; De Braekeleer M
    Cancer Genet; 2014 Mar; 207(3):83-6. PubMed ID: 24726269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous presence of t(2;8)(p12;q24) and t(14;18)(q32;q21) in a B-cell lymphoproliferative disorder with features suggestive of an aggressive variant of splenic marginal-zone lymphoma.
    Batanian JR; Dunphy CH; Richart JM; Petruska PJ; Perkins SL
    Cancer Genet Cytogenet; 2000 Jul; 120(2):136-40. PubMed ID: 10942804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis.
    Watkins AJ; Huang Y; Ye H; Chanudet E; Johnson N; Hamoudi R; Liu H; Dong G; Attygalle A; McPhail ED; Law ME; Isaacson PG; de Leval L; Wotherspoon A; Du MQ
    J Pathol; 2010 Mar; 220(4):461-74. PubMed ID: 20077527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and biological features of B-cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalities.
    Gailllard B; Cornillet-Lefebvre P; Le QH; Maloum K; Pannetier M; Lecoq-Lafon C; Grange B; Jondreville L; Michaux L; Nadal N; Ittel A; Luquet I; Struski S; Lefebvre C; Gaillard JB; Lafage-Pochitaloff M; Balducci E; Penther D; Barin C; Collonge-Rame MA; Jimenez-Poquet M; Richebourg S; Lemaire P; Defasque S; Radford-Weiss I; Bidet A; Susin SA; Nguyen-Khac F; Chapiro E;
    Br J Haematol; 2021 Apr; 193(1):72-82. PubMed ID: 33314017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression to large B-cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases.
    Camacho FI; Mollejo M; Mateo MS; Algara P; Navas C; Hernández JM; Santoja C; Solé F; Sánchez-Beato M; Piris MA
    Am J Surg Pathol; 2001 Oct; 25(10):1268-76. PubMed ID: 11688461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interphase FISH assays for the detection of translocations with breakpoints in immunoglobulin light chain loci.
    Martín-Subero JI; Harder L; Gesk S; Schlegelberger B; Grote W; Martinez-Climent JA; Dyer MJ; Novo FJ; Calasanz MJ; Siebert R
    Int J Cancer; 2002 Mar; 98(3):470-4. PubMed ID: 11920602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splenic lymphoma with villous lymphocytes: analysis of BCL-1 rearrangements and expression of the cyclin D1 gene.
    Jadayel D; Matutes E; Dyer MJ; Brito-Babapulle V; Khohkar MT; Oscier D; Catovsky D
    Blood; 1994 Jun; 83(12):3664-71. PubMed ID: 8204891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA losses in the frequently deleted region of 7q in SMZL.
    Ruiz-Ballesteros E; Mollejo M; Mateo M; Algara P; Martínez P; Piris MA
    Leukemia; 2007 Dec; 21(12):2547-9. PubMed ID: 17625607
    [No Abstract]   [Full Text] [Related]  

  • 15. An integrated genomic and expression analysis of 7q deletion in splenic marginal zone lymphoma.
    Watkins AJ; Hamoudi RA; Zeng N; Yan Q; Huang Y; Liu H; Zhang J; Braggio E; Fonseca R; de Leval L; Isaacson PG; Wotherspoon A; McPhail ED; Dogan A; Du MQ
    PLoS One; 2012; 7(9):e44997. PubMed ID: 23028731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphoma.
    Trøen G; Nygaard V; Jenssen TK; Ikonomou IM; Tierens A; Matutes E; Gruszka-Westwood A; Catovsky D; Myklebost O; Lauritzsen G; Hovig E; Delabie J
    J Mol Diagn; 2004 Nov; 6(4):297-307. PubMed ID: 15507668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma.
    Mateo M; Mollejo M; Villuendas R; Algara P; Sanchez-Beato M; Martínez P; Piris MA
    Am J Pathol; 1999 May; 154(5):1583-9. PubMed ID: 10329610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of immunoglobulin genes in splenic marginal zone lymphoma suggests ongoing mutation.
    Dunn-Walters DK; Boursier L; Spencer J; Isaacson PG
    Hum Pathol; 1998 Jun; 29(6):585-93. PubMed ID: 9635678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A narrow deletion of 7q is common to HCL, and SMZL, but not CLL.
    Andersen CL; Gruszka-Westwood A; Østergaard M; Koch J; Jacobsen E; Kjeldsen E; Nielsen B
    Eur J Haematol; 2004 Jun; 72(6):390-402. PubMed ID: 15128417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and subtype specificity of API2-MALT1 fusion translocations in extranodal, nodal, and splenic marginal zone lymphomas.
    Remstein ED; James CD; Kurtin PJ
    Am J Pathol; 2000 Apr; 156(4):1183-8. PubMed ID: 10751343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.